// App-Quantinova.ai

: The prevalence and impact of autoantibodies among people with bronchiectasis: a data analysis of the EMBARC registry

Researchers

Presenter

  • Michal Shteinberg

Principal Investigators

  • Pierre-Regis Burgel

  • Charles Haworth

  • Katerina Dimakou

  • Adam Hill

  • Michael Loebinger

  • Rosario Menendez

  • Antony Torres

  • Tobias Welte

  • Francesco Blasi

  • Felix Ringshausen

  • Anthony De Soyza

  • Monserrat Vendrell

  • Amelia Shoemark

  • Josje Altenburg

  • Wim Boersma

  • Robert Wilson

  • James Chalmers

  • Stuart Elborn

  • Stefano Aliberti

  • Pieter Goeminne

Medical Centers

  • Medical Center Alkmaar, Alkmaar, Netherlands

  • Dundee Hospital, Dundee, United Kingdom

  • Carmel medical cener and the Technion- Israel institute of Technology, Haifa, Israel

  • Hospital Trueta of Girona, Girona, Spain

  • Hannover Medical School, Hannover, Germany

  • AZ Nikolaas, Sint-Niklaas, Belgium

  • Hospital La Fe, Valencia, Spain

  • Edinburgh University, Edinburgh, United Kingdom

  • Newcastle university, Newcastle, Germany

  • Bichat Hospital, Paris, France

  • Sotiria General Hospital, Athens, Greece

  • Papworth Hospital, Cambridge, United Kingdom

  • University Hospital Vall d'Hebron, Barcelona, Spain

  • The Royal Marsden Hospital, London, United Kingdom

  • Dundee University, Dundee, United Kingdom

  • Hospital Clinic Barcelona, Barcelona, Spain

  • AMC, Amsterdam University, Amsterdam, Netherlands

  • Milan University, Milano, Italy

  • Queen's University Belfast, Belfast, United Kingdom

Locations

  • United Kingdom

  • Israel

  • Germany

  • Italy

  • Belgium

  • France

  • Netherlands

  • Greece

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multicenteric

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A